Parathyroid hormone-related protein analog RS-66271 is an effective therapy for impaired bone healing in rabbits on corticosteroid therapy

Bone

Volumn 26, Issue 5, 2000, Pages 437-442

  Bostrom, M P G ^a   Gamradt, S C ^a   Asnis, P ^a   Vickery, B H ^a   Hill, E ^b   Avnur, Z ^b   Waters, R V ^b  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b ROCHE BIOSCIENCE   (United States)

Author keywords

Corticosteroids; Fracture healing; Parathyroid hormone (PTH); Parathyroid hormone related protein (PTHrP); Prednisone; Rabbits

Indexed keywords

PARATHYROID HORMONE RELATED PROTEIN; PARATHYROID HORMONE RELATED PROTEIN[1-34]AMIDE; PREDNISONE; RS 66271; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FRACTURE HEALING; MALE; NONHUMAN; OSTEOPENIA; RABBIT; RADIOGRAPHY;

ANIMALS; FRACTURE HEALING; MALE; PREDNISONE; RABBITS; TERIPARATIDE;

EID: 0034114305     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(00)00251-9     Document Type: Article

References (42)

1. Adinoff A.D., Hollister J.R. Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med. 309:1983;265-268.
2. Andreassen T.T., Ejersted C., Oxlund H. Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures. J Bone Miner Res. 14:1999;960-968.
3. Andreen O., Larsson S.E. Effects of parathyroidectomy and vitamin D on fracture healing. Fracture biomechanics in rats after parathyroidectomy and treatment with 1,25-dihydroxycholecalciferol. Acta Orthop Scand. 54:1983;805-809.
4. Bab I., Gazit D., Chorev M., Muhlrad A., Shteyer A., Greenberg Z., Namdar M., Kahn A. Histone H4-related osteogenic growth peptide (OGP) A novel circulating stimulator of osteoblastic activity . Eur Med Biol Org J. 11:1992;1867-1873.
5. Blunt J.W., Plotz C.M., Lattes R., Meyer K., Ragan C. Effect of cortisone on experimental fractures in the rabbit. Proc Soc Exp Biol NY. 73:1950;678.
6. Bostrom M.P.G., Asnis P., Toledano T., Hill E., Avnur Z., Vickery B.H. The enhancement of fracture healing in the rat using a PTHrP analog. Trans Comb Orthop Res Soc. 3:1998;27.
7. Bostrom M., Lane J.M., Tomin E., Browne M., Berberian W., Turek T., Smith J., Wozney J., Schildhauer T. Use of bone morphogenetic protein-2 in the rabbit ulnar nonunion model. Clin Orthop. 327:1996;272-282.
8. Caulfield J., Kimmel D.B., Waters R.V., Vickery B.H. Bone structure and turnover following treatment of glucocorticoid osteopenia in rabbits with RS-66271. J Bone Miner Res. 10:(suppl.):1995;S197.
9. Duthie R.B., Barker A.N. Histochemistry of preosseous stage of bone repair autoradiography. Effect of cortisone. J Bone Jt Surg. 37:1955;691-710.
10. Eastell R., Reid D.M., Compston J., Cooper C., Fogelman I., Francis R.M., Hosking D.J., Purdie D.W., Ralston S.H., Reeve J., Russell R.G., Stevenson J.C., Torgerson D.J. A UK consensus group on management of glucocorticoid-induced osteoporosis An update . J Intern Med. 244:1998;271-292.
11. Einhorn T.A. Enhancement of fracture-healing. J Bone Jt Surg [Am]. 77:1995;940-956.
12. Einhorn T.A., Majeska R.J., Rush E.B., Levine P.M., Horowitz M.C. The expression of cytokine activity by fracture callus. J Bone Miner Res. 10:1995;1272-1281.
13. Finkelstein J.S. Pharmacological mechanisms of therapeutics parathyroid hormone . Bilezikian J. Principles of Bone Biology. 1996;993-1005 Academic, New York.
14. Finkelstein J.S., Klibanski A., Schaefer E.H., Hornstein M.D., Schiff I., Neer R.M. Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency. N Engl J Med. 331:1994;1618-1623.
15. Gallagher J.C. PTHrP(1-34) analog, semparatide acetate (RS-66271), causes sustained increases in spine in postmenopausal osteoporotic women Two randomized placebo-controlled trials . J Bone Miner Res. 14:(Suppl.):1999;S136.
16. Goforth P., Gudas C.J. Effects of steroids on wound healing A review of the literature . J Foot Surg. 19:1980;22-28.
17. Grardel B., Sutter B., Flautre B., Viguier E., Lavaste F., Hardouin P. Effects of glucocorticoids on skeletal growth in rabbits evaluated by dual-photon absorptiometry, microscopic connectivity and vertebral compressive strength. Osteopor Int. 4:1994;204-210.
18. Hefti E., Trechsel U., Bonjour J.P., Fleisch H., Schenk R. Increase of whole-body calcium and skeletal mass in normal and osteoporotic adult rats treated with parathyroid hormone. Clin Sci. 62:1982;389-396.
19. Hellewell A.B., Beljan J.R., Goldman M. Effect of chronic administration of glucocorticoid (prednisolone) on the rate of healing of experimental osseous defects. Clin Orthop. 100:1974;349-355.
20. Hock J.M., Gera I., Fonseca J., Raisz L.G. Human parathyroid hormone-(1-34) increases bone mass in ovarectomized and orchidectomized rats. Endocrinology. 122:1988;2899-2904.
21. Hodsman A.B., Fraher L.J., Watson P.H., Ostbye T., Stitt L.W., Adachi J.D., Taves D.H., Drost D. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis. J Clin Endocrinol Metab. 82:1997;620-628.
22. Lane N.E., Lukert B. The science and therapy of glucocorticoid-induced bone loss. Endocrinol Metab Clin Am. 27:1998;465-483.
23. Lane N.E., Sanchez S., Modin G.W., Genant H.K., Ini E., Arnaud C.D. Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial. J Clin Invest. 102:1998;1627-1633.
24. 3 on bone tissue in the rabbit Studies on fracture healing, disuse osteoporosis, and prednisone osteoporosis . Calcif Tissue Int. 36:1984;591-595.
25. Linkhart T.A., Mohan S., Baylink D.J. Growth factors for bone growth and repair IGF, TGF beta and BMP . Bone. 19:(Suppl.):1996;1S-12S.
26. Liu C.C., Kalu D.N., Salerno E., Echon R., Hollis B.W., Ray M. Preexisting bone loss associated with ovariectomy in rats is reversed by parathyroid hormone. J Bone Miner Res. 6:1991;1071-1080.
27. McEvoy C.E., Ensrud K.E., Bender E., Genant H.K., Yu W., Griffith J.M., Niewoehner D.E. Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 157:1998;704-709.
28. Neer, M., Slovik, D. M., Daly, M., Potts, T. J., and Nussbaum, S. R. Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol. Osteopor Int 3(Suppl. 1)5:204-205; 1993.
29. Norrdin R.W., Shih M.S. Systemic effects of prostaglandin E2 on vertebral trabecular remodeling in beagles used in a healing study. Calcif Tissue Int. 42:1988;363-368.
30. Roe E.B., Sanchez S.D., del Puerto G.A., Piernini E., Bacchetti P., Cann C.E., Arnaud C.D. Parathyroid hormone 1-34 (hPTH 1-34) and estrogen produce dramatic bone density increases in postmenopausal osteoporosis - results from a placebo-controlled randomized trial. J Bone Miner Res. 14:1999;S137.
31. Sissons H.S., Hadfield G.H. The influence of cortisone on the repair of experimental fractures in the rabbit. Br J Surg. 39:1951;172-178.
32. Slovik D.M., Rosenthal D.I., Doppelt S.H., Potts J.T.J., Daly M.A., Campbell J.A., Neer R.M. Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D. J Bone Miner Res. 1:1986;377-381.
33. Storey E. The effect of cortisone on normal and fractured bone in the rat. Austr NZ J Surg. 30:1960;37-44.
34. Thompson J.S., Urist M.R. Effects of cortisone on bone metabolism in intact and thyroidectomized rabbits. Calcif Tissue Res. 13:1973;197-215.
35. Waters, R. V., Bergstrom, K., Briones, W., Vickery, B. H., and Kimmel, D. B. Prednisone causes bone loss in rabbits. In: The Endocrine Society Program and Abstracts of the 77th Annual Meeting, June 14-17, 1995, Washington, DC. 1995; Abstract P3-510.
36. Waters, R. V., Gamradt, S. C., Bostrom, M. P. G., Asnis, P., Avnur, Z., and Hill, E. Systemic corticosteroids inhibit bone healing in a rabbit ulnar osteotomy model. Acta Ortopaed Scand. In press.
37. White A.A., Panjabi M.M., Southwick W.O. The four biomechanical stages of fracture repair. J Bone Jt Surg [Am]. 59:1977;188-192.
38. Wiancko K.O., Kowalewski K. Strength of callus in fractured humerus of rats treated by anti-anabolic and anabolic compounds. Acta Endocrinol. 36:1961;310-318.
39. Verstraeten A., Dequeker J. Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis Effect of low dose corticosteroids . Ann Rheum Dis. 45:1986;852-857.
40. Vortkamp A., Pathi S., Peretti G.M., Caruso E.M., Zaleske D.J., Tabin C.J. Recapitulation of signals regulating embryonic bone formation during postnatal growth and in fracture repair. Mech Dev. 71:1998;65-76.
41. Vickery B.H., Avnur Z., Cheng Y., Chiou S.S., Leaffer D., Caulfield J.P., Kimmel D.B., Ho T., Krstenansky J.L. RS-66271, a C-terminally substituted analog of human parathyroid hormone-related protein (1-34), increases trabecular and cortical bone in ovarectomized, osteopenic rats. J Bone Miner Res. 11:1996;1943-1951.
42. Vickery B.H., Avnur Z., McRae G.I., Hill E., Krstenansky J.L. Bone formation may be uncoupled from resorption as demonstrated by a new class of hPTHrP(1-34) analogs in both rapid and slow models of bone turnover. Whitfield M.P. Anabolic Treatments for Osteoporosis. 1997;152-173 CRC, New York.